1 / 43

Pathogenesis of Granulomatous & Interstitial Airways Disease

Pathogenesis of Granulomatous & Interstitial Airways Disease. Granulomatous Disease Necrotizing vs Non-necrotizing. Most necrotizing granulomatous disease is infectious (TB!) Responsible organism usually demonstrable in tissue All specimens should be cultured

olympe
Download Presentation

Pathogenesis of Granulomatous & Interstitial Airways Disease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Pathogenesis of Granulomatous & Interstitial Airways Disease

  2. Granulomatous DiseaseNecrotizing vs Non-necrotizing

  3. Most necrotizing granulomatous disease is infectious (TB!) • Responsible organism usually demonstrable in tissue • All specimens should be cultured • Non-infectious granulomatous inflammation – sarcoidosis, Wegener’s granulomatosis, Crohn’s, etc.

  4. Tuberculosis The mycobacteria that cause TB in man: • Mycobacterium tuberculosis • Lung is most common primary site • Droplet infection = inhalation of infective droplets coughed or sneezed by a patient with TB • Mycobacterium bovis • Drinking milk from infected cows – intestinal & tonsillar lesions • M. avium & M. intracellulare (MAC complex) • Opportunistic infection in IC

  5. Mycobacteria: • Aerobic organisms • Difficult to stain • waxy cell wall • scanty in tissue • slow growth in culture • PCR • Difficult to kill (dormancy) • No toxins or histolytic enzymes • Inhibition of phagosome-lysosome fusion & killing by macrophages • Induce delayed hypersensitivity (type IV - T cell mediated) • Destructive effects

  6. Epidemiology • Developed countries: • Considerable fall in incidence and mortality in 20th century • A disease of the elderly: • Reactivation of quiescent infection acquired in youth • Recent resurgence: • AIDS, urban deprivation, immigrant & refugee populations

  7. 1/3 world population infected (~1.7 billion) • 8 million new cases every year • 95% in developing countries • 3 million deaths every year • Largest cause of a death from a single pathogen • TB kills twice as many adults as AIDS, malaria and other parasitic diseases combined

  8. TB & HIV • Marked resurgence • Poorer communities, drug abuse • Multidrug resistant strains have emerged • 6 million people world-wide have dual infection, majority in sub-Saharan Africa • HIV infection – particularly aggressive TB – widespread, disseminated & poor host response • HIV infection promotes infection with opportunistic mycobacteria

  9. Primary TB: • First time infection • Formerly found mainly in children, now encountered in adults • Secondary/Postprimary TB: • Adult type • Reactivation of a dormant primary lesion • Re-infection from re-inhalation

  10. Primary Tuberculosis • Transmitted through inhalation of infected droplets • Single tuberculous granuloma (tubercle): • within parenchyma (usually subpleural/periphery) = Ghon focus • also in hilar lymph nodes (common) = Ghon complex

  11. Ghon Complex - Sequence of Events • Inhaled bacilli ingested by alveolar macrophages • Macrophages with bacilli aggregate, forming microscopic nodules that deform architecture • Development of T-cell mediated immunity: CD4 (helper) & CD8 (cytotoxic) • CD4 – interferon – secretory changes in macrophages – epithelioid (activated) histiocytes • CD8 – kill macrophages – resulting in caseous necrosis • Fusion of macrophages to form Langerhan’s type giant cells • Mantle of B lymphocytes

  12. Primary TBResolution vs. Progression • RESOLUTION: • Most common (if immunocompetent) • Development of a fibrous capsule - eventually calcified scar • Indefintely viable dormant bacteria

  13. PROGRESSION: 1. Tuberculous bronchopneumonia • Erosion into bronchus - dissemination within bronchial tree (‘galloping consumption’) • Continuing casseation - cavitary fibrocasseous lesions 2.Pleural spread • effusion, TB empyema 3. Miliary TB (haematogenous dissemination) • Remainder of lung • Cervical lymph nodes (scrofula) • Meninges (tuberculous meningitis) • Kidneys & adrenals • Bones (tuberculous osteomyelitis) • veterbral TB = Pott’s disease • Fallopian tubes & epididymis Fibrocaseous Miliary

  14. Secondary TB • Reactivation of dormant lesion • Re-infection Associations - alcoholism, diabetes, silicosis & immunosuppression • Pulmonary • Resolution or progression • N.B. Extensive firosis in healing process: • Pulmonary & pleural fibrosis • Bronchiectasis

  15. TB in the elderly & immunocompromised • TB in the elderly: • Disseminated miliary TB – (non-reactive TB) little granulomatous response, necrosis, DAD • TB in AIDS: • Conventional morphology • Granulomas poorly formed • Opportunistic MAC from environment

  16. Necrotizing Granulomas - Other Infectious Causes • Bacteria: • Brucellosis • Fungi: • Histoplasma, Coccidioides, Cryptococcus & Blastomyces • Parasitic roundworm: • Dirofilaria

  17. Sarcoidosis • Systemic disease of unkown aetiology • Characterized by non-caseating granulomas in many tissues & organs • Lungs, lymph nodes, spleen, liver, bone marrow, skin, eye, salivary glands and less frequently – heart, kidneys, CNS, endocrine glands – pituitary

  18. Sarcoidosis • Occurs worldwide but geographical variation • more prevalent at higher latitudes – Ireland, Scandinavia & North America (African Americans) • 10 per 105 in UK • Females > Males, peak incidence 30 - 40 yrs

  19. Exact aetiology & pathogenesis unclear • Several immunologic abnormlaities • Enhanced cellular hypersensitivity at involved sites – but depressed elsewhere • Anergy to common skin test antigens • Generally driven by CD4 T cells • Increased CD4 lymphocytes in the lung

  20. Clinical: • Variable depending on organ(s) • Mild non-specific chest complaints, cough, dyspnoea • 1/3 – Erythema nodosum • Radiology: • Bilateral hilar lymphadenopathy

  21. Sarcodosis in the Lung • Non-caseating granulomas (classic) • Tight clusters of epithelioid histiocytes and occassional MNGCs • Tight rim of concentric fibroblasts , few lymphocytes (‘naked granulomas’) • Schaumann bodies • Laminated concretions (Ca2+ & protein) • Asteroid bodies • Stellate inclusions • Histological diagnosis of exclusion • DDx – infection, berylliosis, HP, IVDA, adjacent to tumour / lymphoma

  22. Sarcoidosis - Prognosis • Unpredictable clinical course • Progessive chronicity or alternating activity & remission • ~ 70% recover with steroid Rx • ~ 35% progress to interisital fibrosis & cor pulmonale

  23. Interstitial Lung Disease • Heterogeneous group of non-infectious, non-neoplastic disorders • Predominanly diffuse and usually chronic • Damage to the lung parenchyma (varying intersitial inflammation & fibrosis) • a.k.a alveolitis & pulmonary fibrosis • Restrictive lung disorders

  24. Acute (e.g. DAD) vs. Chronic • NB - Clinical, Radiology & Pathology correlation! • Aetiology / associations: • idiopathic, collagen vascular disease, drugs & toxins, environmental

  25. Chronic ILD • FIBROSING: • USUAL INTERSTITIAL PNEUMONIA (UIP/CFA/IPF) • Non-specific interstitial pneumonia (NSIP) • Cryptogenic organizing pneumonia (COP) • Connective tissue disease • Pneumoconiosis • Drug rections • Raditation pneumonitis • Lymphocytic interstitial pneumonitis (LIP) • GRANULOMATOUS • Sarcoidosis • Hypersensitivity pneumonitis • SMOKING-RELATED: • Respiratory bronchiolitis (RB) • Desquamative* interstitial pneumonitis (DIP)

  26. Usual Interstitial Pneumonia • Progressive fibrosing disorder of unknown cause • ? Repeated acute lung injury (unknown agent) • Patchy lung involvement – worst at bases, subpleural & paraseptal distribution • Dense fibrosis – remodelling of lung architecture (‘honeycombing’) • Fibroblastic foci

  27. Usual Interstitial Pneumonia • Adults 30 to 60 yrs • Gradual onset of symptoms: dyspnea, non-prod cough • Median survival ~ 3 years • Respiratory and heart failure (cor pulmonale) • Require transplantation

  28. Pneumoconioses • Disorders caused by inhalation of inorganic elements, primarily mineral dusts. • Injury is determined by: • Length of exposure • Physicochemical characteristics • Host factors • Carbon dust - Coal worker’s pneumoconiosis: • Anthracosis • Simple coal worker’s pneumoconiosis • Progressive massive fibrosis • Silicosis • Silicotic nodules • TB risk • Asbestos • Asbestosis (pulmonary fibrosis) • Pleural disease (fibrous plaques, mesothelioma).

  29. Farmer’s lung Thermophilic actinomycetes in hay Pigeon breeder’s Air-condition lung Thermophilic bacteria Hypersensitivity Pneumonitis • Immune-mediated granulomatous inflammation caused by inhaling organic dusts • Mix type III (immune-complex deposition) & type IV (cellular mediated) hypersensitivity • Diffuse interstitial fibrosis (> upper lobes) • Progressive - honeycomb & respiratory failure

More Related